Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.10 is 70% below its 5-year average of 3.66, near the low end of its 5-year range (0.08–15.86).
As of the fiscal period ended Tuesday, June 30, 2026. 83.29% below its 12-month average of 6.56.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.10.
QUICK RATIO (ACID-TEST)
1.10
QUICK RATIO (ACID-TEST) AVG TTM
6.56
QUICK RATIO (ACID-TEST) AVG 3Y
5.08
QUICK RATIO (ACID-TEST) AVG 5Y
3.66
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-83.29%
CURRENT VS 3Y AVG
-78.43%
CURRENT VS 5Y AVG
-70.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.25
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
-66.25%
vs the sector median at left
Nexalin Technology, Inc.
Market Cap
$3.52M
Quick Ratio (Acid-Test)
1.10
TTM Avg
6.56
3Y Avg
5.08
5Y Avg
3.66
Market Cap
$3.49M
Quick Ratio (Acid-Test)
1.97
TTM Avg
1.45
3Y Avg
2.21
5Y Avg
4.94
Market Cap
$3.42M
Quick Ratio (Acid-Test)
3.73
TTM Avg
3.25
3Y Avg
4.33
5Y Avg
4.33
Market Cap
$3.40M
Quick Ratio (Acid-Test)
0.08
TTM Avg
0.52
3Y Avg
0.43
5Y Avg
0.47
Market Cap
$3.85M
Quick Ratio (Acid-Test)
2.01
TTM Avg
0.91
3Y Avg
1.26
5Y Avg
1.78
Market Cap
$3.27M
Quick Ratio (Acid-Test)
5.42
TTM Avg
3.49
3Y Avg
5.10
5Y Avg
6.32
Market Cap
$3.23M
Quick Ratio (Acid-Test)
8.13
TTM Avg
4.58
3Y Avg
2.68
5Y Avg
3.19
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | $3.52M | 1.10 | 6.56 | 5.08 | 3.66 |
| Evogene Ltd. (EVGN)vs › | $3.68M | 3.54 | 2.77 | 4.28 | 5.12 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 1.97 | 1.45 | 2.21 | 4.94 |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | 3.73 | 3.25 | 4.33 | 4.33 |
| Moolec Science S.A. (MLEC)vs › | $3.40M | 0.08 | 0.52 | 0.43 | 0.47 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.85M | 2.01 | 0.91 | 1.26 | 1.78 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | 5.42 | 3.49 | 5.10 | 6.32 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | 8.13 | 4.58 | 2.68 | 3.19 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | 1.15 | 2.58 | 1.43 | 2.20 |
Quick Ratio
1.10
Excludes inventory
Current Ratio
1.25
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.10 |
| 2026-03-31 | 3.85 |
| 2025-12-31 | 4.70 |
| 2025-09-30 | 13.03 |
| 2025-06-30 | 10.15 |
| 2025-03-31 | 4.25 |
| 2024-12-31 | 6.93 |
| 2024-09-30 | 15.86 |
| 2024-06-30 | 4.89 |
| 2024-03-31 | 4.75 |
| 2023-12-31 | 7.70 |
| 2023-09-30 | 3.43 |
| 2023-06-30 | 4.19 |
| 2023-03-31 | 4.78 |
| 2022-12-31 | 3.73 |
| 2022-09-30 | 4.14 |
| 2022-06-30 | 0.15 |
| 2022-03-31 | 0.22 |
| 2021-12-31 | 0.31 |
| 2021-09-30 | 0.08 |
| 2021-06-30 | 0.17 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
